Skip Navigation



JAC Advance Access published online on November 10, 2004

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh493
© 2004 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
54/6/1040    most recent
dkh493v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Malbruny, B.
Right arrow Articles by Leclercq, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malbruny, B.
Right arrow Articles by Leclercq, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received June 29, 2004
Revised October 1, 2004
Accepted October 5, 2004

Original article

A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand

Brigitte Malbruny 1, Anja M. Werno 2, Trevor P. Anderson 2, David R. Murdoch 3, and Roland Leclercq 1*

1 Service de Microbiologie, CHU Côte de Nacre, 14033 Caen, France
2 Department of Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand
3 Department of Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand; Department of Pathology, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand

* To whom correspondence should be addressed.
Roland Leclercq, E-mail: leclercq-r{at}chu-caen.fr


   Abstract

Objectives: To characterize a new type of resistance to clindamycin in Streptococcus agalactiae.

Methods: Nineteen erythromycin-susceptible, clindamycin-resistant S. agalactiae isolates from New Zealand were studied. MICs of macrolide, lincosamide and streptogramin antibiotics were determined. Clindamycin and streptogramin resistance genes were searched for by PCR. Isolates were compared by serotyping and by DNA macrorestriction patterns determined by PFGE. Conjugative transfer of resistance traits to recipient strains of S. agalactiae and Enterococcus faecium was assayed.

Results: The 19 S. agalactiae isolates were intermediate or resistant to clindamycin (MIC range: 0.5-2 mg/L) and lincomycin (MIC range: 1-8 mg/L) and had high MICs of dalfopristin (4-32 mg/L), a streptogramin A-type antibiotic, compared with controls. By contrast, the strains were susceptible to macrolides and quinupristin, a streptogramin B-type antibiotic. This new phenotype was called LSA (lincosamide-streptogramin A). Clindamycin resistance could not be transferred to recipient strains. Thirteen isolates belonged to serotype III and to a single PFGE genotype A, and five isolates belonged to serotype I and to genotype B. One isolate was non-typeable and belonged to a distinct genotype C.

Conclusions: We have characterized a new LSA phenotype in S. agalactiae. Analysis of restriction patterns of S. agalactiae chromosomal DNA showed that the resistance was spread in a minimum of three bacterial clones. The genetic and biochemical basis for the resistance remains unknown.

Keywords: streptococci; resistance mechanism; inhibition of protein synthesis; drug resistance; group B streptococcus.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
X. Zeng, F. Kong, H. Wang, A. Darbar, and G. L. Gilbert
Simultaneous Detection of Nine Antibiotic Resistance-Related Genes in Streptococcus agalactiae Using Multiplex PCR and Reverse Line Blot Hybridization Assay
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 204 - 209.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Dupuis and R. Leclercq
Activity of a New Oral Streptogramin, XRP2868, against Gram-Positive Cocci Harboring Various Mechanisms of Resistance to Streptogramins
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 237 - 242.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. Novotna, V. Adamkova, J. Janata, O. Melter, and J. Spizek
Prevalence of Resistance Mechanisms against Macrolides and Lincosamides in Methicillin-Resistant Coagulase-Negative Staphylococci in the Czech Republic and Occurrence of an Undefined Mechanism of Resistance to Lincosamides
Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3586 - 3589.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Achard, C. Villers, V. Pichereau, and R. Leclercq
New lnu(C) Gene Conferring Resistance to Lincomycin by Nucleotidylation in Streptococcus agalactiae UCN36
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2716 - 2719.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.